News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
143,659 Results
Type
Article (5335)
Company Profile (96)
Press Release (138222)
Multimedia
Podcasts (25)
Webinars (7)
Section
Business (43753)
Career Advice (210)
Deals (6461)
Drug Delivery (25)
Drug Development (19298)
Employer Resources (18)
FDA (1771)
Job Trends (2998)
News (70013)
Policy (4098)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (308)
Accelerated approval (12)
Adcomms (30)
Allergies (32)
Alliances (12060)
ALS (57)
Alzheimer's disease (543)
Antibody-drug conjugate (ADC) (336)
Approvals (1836)
Artificial intelligence (121)
Autoimmune disease (60)
Automation (12)
Bankruptcy (47)
Best Places to Work (2470)
BIOSECURE Act (15)
Biosimilars (33)
Biotechnology (86)
Bladder cancer (64)
Brain cancer (14)
Breast cancer (301)
Cancer (1903)
Cardiovascular disease (57)
Career advice (202)
Career pathing (5)
CAR-T (133)
Cell therapy (331)
Cervical cancer (15)
Clinical research (17101)
Collaboration (641)
Compensation (289)
Complete response letters (10)
COVID-19 (508)
CRISPR (28)
C-suite (380)
Cystic fibrosis (45)
Data (2238)
Denatured (1)
Depression (24)
Diabetes (117)
Diagnostics (778)
Digital health (1)
Diversity, equity & inclusion (8)
Drug discovery (100)
Drug pricing (17)
Drug shortages (3)
Duchenne muscular dystrophy (56)
Earnings (14253)
Editorial (8)
Employer resources (18)
Events (27766)
Executive appointments (393)
FDA (2564)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (14)
Funding (499)
Gene editing (57)
Generative AI (15)
Gene therapy (177)
GLP-1 (185)
Government (421)
Guidances (78)
Healthcare (1871)
HIV (9)
Huntington's disease (12)
IgA nephropathy (46)
Immunology and inflammation (75)
Immuno-oncology (21)
Indications (31)
Infectious disease (569)
Inflammatory bowel disease (80)
Inflation Reduction Act (3)
Influenza (35)
Intellectual property (81)
Interviews (18)
IPO (3108)
IRA (7)
Job creations (687)
Job search strategy (185)
JPM (12)
Kidney cancer (3)
Labor market (16)
Layoffs (59)
Leadership (2)
Legal (661)
Liver cancer (16)
Longevity (3)
Lung cancer (255)
Lymphoma (181)
Machine learning (17)
Management (4)
Manufacturing (278)
MASH (19)
Medical device (429)
Medtech (431)
Mergers & acquisitions (3696)
Metabolic disorders (249)
Multiple sclerosis (51)
NASH (2)
Neurodegenerative disease (92)
Neuropsychiatric disorders (19)
Neuroscience (889)
Neurotech (1)
NextGen: Class of 2026 (897)
Non-profit (287)
Now hiring (7)
Obesity (103)
Opinion (55)
Ovarian cancer (92)
Pain (45)
Pancreatic cancer (84)
Parkinson's disease (108)
Partnered (8)
Patents (138)
Patient recruitment (184)
Peanut (17)
People (17455)
Pharmaceutical (12)
Phase 1 (6757)
Phase 2 (8052)
Phase 3 (4411)
Pipeline (1658)
Policy (43)
Postmarket research (226)
Preclinical (2858)
Press Release (51)
Prostate cancer (63)
Psychedelics (18)
Radiopharmaceuticals (77)
Rare diseases (192)
Real estate (1498)
Recruiting (10)
Regulatory (3993)
Reports (15)
Research institute (328)
Resumes & cover letters (20)
Rett syndrome (9)
RNA editing (4)
RSV (16)
Schizophrenia (19)
Series A (101)
Series B (75)
Service/supplier (2)
Sickle cell disease (27)
Special edition (5)
Spinal muscular atrophy (41)
Sponsored (6)
Startups (1020)
State (1)
Stomach cancer (9)
Supply chain (24)
Tariffs (11)
The Weekly (24)
Vaccines (150)
Venture capital (22)
Weight loss (47)
Women's health (9)
Worklife (2)
Date
Last 7 days (171)
Last 30 days (635)
Last 365 days (9448)
2026 (875)
2025 (9552)
2024 (10177)
2023 (10773)
2022 (12896)
2021 (13394)
2020 (10430)
2019 (7039)
2018 (5564)
2017 (6334)
2016 (5806)
2015 (6615)
2014 (5073)
2013 (4175)
2012 (4512)
2011 (4950)
2010 (4570)
Location
Africa (153)
Alabama (53)
Alaska (1)
Arizona (36)
Arkansas (2)
Asia (10188)
Australia (2113)
California (3872)
Canada (946)
China (495)
Colorado (73)
Connecticut (138)
Delaware (98)
Europe (20722)
Florida (399)
Georgia (54)
Hawaii (2)
Idaho (11)
Illinois (223)
India (22)
Indiana (197)
Iowa (3)
Japan (167)
Kansas (14)
Kentucky (3)
Louisiana (3)
Maine (2)
Maryland (410)
Massachusetts (2963)
Michigan (98)
Minnesota (158)
Mississippi (1)
Missouri (13)
Montana (10)
Nebraska (2)
Nevada (24)
New Hampshire (7)
New Jersey (806)
New Mexico (6)
New York (888)
North Carolina (450)
North Dakota (5)
Northern California (1974)
Ohio (66)
Oklahoma (7)
Oregon (7)
Pennsylvania (652)
Puerto Rico (8)
Rhode Island (5)
South America (212)
South Carolina (4)
Southern California (1461)
Tennessee (24)
Texas (512)
United States (12340)
Utah (35)
Virginia (30)
Washington D.C. (9)
Washington State (516)
West Virginia (1)
Wisconsin (22)
143,659 Results for "adc biotechnology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
IN PARTNERSHIP WITH LOTTE BIOLOGICS
LOTTE Biologics Tightens Global Quality as Syracuse ADC Hub Ramps for 2026
With inspections always on the table, LOTTE Biologics is pushing a proactive, quality first culture across its dual hubs in Syracuse and Songdo, backing its new single‑use ADC facility with rigorous training, self‑audits and real‑time regulatory surveillance.
January 19, 2026
·
2 min read
·
Jennifer Smith-Parker
Press Releases
DS3790 Enters Clinical Development as First DXd ADC in Hematology from Industry-Leading ADC Portfolio of Daiichi Sankyo
February 5, 2026
·
5 min read
Antibody-drug conjugate (ADC)
Daiichi Sankyo Dumps Next-Gen ADC From Development Pipeline
DS-9606 was supposed to be the first antibody-drug conjugate in Daiichi Sankyo’s line of anti-cancer assets to use a modified pyrrolobenzodiazepine payload.
February 3, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Unchained Labs Cracks the Code on ADC Characterization
January 6, 2026
·
1 min read
Press Releases
Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform
February 4, 2026
·
4 min read
Press Releases
PDS Biotechnology Announces Translational Data Showing Strong Immunological and Clinical Activity of PDS0101 and PDS01ADC Presented at SITC 2025
November 11, 2025
·
10 min read
Press Releases
New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 31, 2025
·
8 min read
Press Releases
Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform
February 5, 2026
·
2 min read
Lung cancer
Roche Spends $570M on Another ADC Agreement With China’s MediLink
Roche first partnered with MediLink in January 2024, likewise for an antibody-drug conjugate for solid tumors.
January 9, 2026
·
1 min read
·
Tristan Manalac
Press Releases
ADC Therapeutics Announces New Employee Inducement Grant - January 2, 2026
January 5, 2026
·
5 min read
1 of 14,366
Next
